Skip to main content

What is Ninlaro used for?

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 27, 2025.

Official Answer by Drugs.com

Ninlaro (ixazomib citrate) is a proteasome inhibitor used to treat patients with multiple myleoma. Multiple myeloma is a type of cancer of the bone marrow, which occurs when plasma cells grow uncontrolled.

Ninlaro comes in the from of a capsule. The Food and Drug Administration (FDA) has specifically approved Ninlaro for use in combination with a thalidomide analog called lenalidomide (Revlimid) and dexamethasone, a corticosteroid. Ninlaro is used in multiple myleoma patients who have received at least one prior therapy.

Ninlaro works by preventing the break down of all the 'garbage' proteins that myeloma cell generate, which leads to them building up and killing the myeloma cells.

Ninlaro is made by Takeda.

References

Read next

What is CAR T-cell therapy and how does it work?

CAR T-cell therapy is a personalized treatment that uses a patient's own immune cells to fight certain cancers and autoimmune diseases. By harnessing and reprogramming a patient’s own immune cells, this therapy offers a new option for those who have not responded to conventional treatments. 

Continue reading

What are CELMoD agents and how do they work?

CELMoD agents (cereblon E3 ligase modulators) are a new drug class that represents a transformative advancement in targeted protein degradation (TPD), offering novel therapeutic strategies for hematologic malignancies.

Continue reading

Is Velcade a type of chemotherapy?

Velcade is not a traditional form of chemotherapy (chemo). Velcade is a targeted drug therapy in the class of drugs known as proteasome inhibitors. Continue reading

See also:

Related medical questions

Drug information

Related support groups